Dr. Ankur Bahl

Dr. Ankur Bahl is a renowned medical oncologist with over 14 years of experience in this field. He holds clinical expertise in immunotherapy, targeted therapies in combination with chemotherapy, hormonal therapy, and supportive and palliative care.

He is the lead author of the largest real-world Indian data on targeted therapy (cetuximab) in head & neck cancer, acute myeloid leukemia treatment, and human papilloma virus trends in the Indian Population.

In addition, Dr. Bahl is the lead founder of various innovative oncology educational platforms and networks (international and national) evidence-based debates in oncology, live oncology tumor boards, master classes, and workshops in oncology.